Biomarin Pharmaceutical Inc
BMRN
ISIN null / Valor 729021
Biomarin Pharmaceutical Inc
UMushroom community rating:
About company
Biomarin Pharmaceutical Inc, founded in 1997, focuses on developing and commercializing therapies for rare genetic disorders. The company has successfully brought to market treatments for conditions such as achondroplasia, severe hemophilia A, and several inherited and lysosomal storage diseases. Utilizing a range of treatment approaches, Biomarin continues to expand its portfolio with a robust pipeline of investigational medicines currently undergoing clinical and preclinical trials. This strategic emphasis on specialized therapies aims to address significant unmet medical needs within the rare disease community.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
10853 M
Market cap (USD)
2,733,265
Daily traded volume (Shares)
66.3 / 65.27
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
